部門紹介

2019年

◆発表論文(英文)

<原著論文>

1.Role of TLR5 in inflammation and tissue damage after intestinal ischemia-reperfusion injury.New
Ito H, Sadatomo A, Inoue Y, Yamada N, Aizawa E, Hishida E, Kamata R, Karasawa T, Kimura H, Watanabe S, Komada T, Horie H, Kitayama J, Sata N, Takahashi M.

Biochem Biophys Res Commun. 2019 Aug 28. pii: S0006-291X(19)31606-7. doi: 10.1016/j.bbrc.2019.08.083. [Epub ahead of print]


2.Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patients.New
Masuda T, Ohara K, Nagayama I, Matsuoka R, Murakami T, Nakagawa S, Oka K, Asakura M, Igarashi Y, Fukaya Y, Miyazawa Y, Maeshima A, Akimoto T, Saito O, Nagata D.
Int Urol Nephrol. 2019 Sep;51(9):1623-1629.

3.Effcts of the sodium-glucose cotransporter2 inhibitor dapagliflozin on fluis distribution: A comparison study with furosemide and tolvaptan.New

Ohara K, Masuda T, Murakami T, Imai T, Yoshizawa H, Nakagawa S, Okada M, Miki A, Myoga A, Sugase T, Sekiguchi C, Miyazawa Y, Maeshima A, Akimoto T, Saito O, Muto S, Nagat D.

Nephrology(Carlton).2019 Sep;24(9):904-911.

4.
Crucial role of NLRP3 inflammasome in the development of peritoneal dialysis-related peritoneal fibrosis.

Hishida E, Ito H, Komada T, Karasawa T, kimura H, Watanabe S, Kamata R, Aizawa E, Kasahara T, Morishita Y, Akimoto T, Nagata D, Takahashi M.
Sci Rep. 9(1):10363. 2019

5.Effect of Renal Tubule-Specific Knockdown of the Na+/H+ Exchanger NHE3 in Akita Diabetic Mice.
Onishi A, Fu Y, Darshi M, Crespo-Masip M, Huang W, Song P, Patel R, Kim YC, Nespoux J, Freeman B, Soleimani M, Thomson SC, Sharma K, Vallon V.
Am J Physiol Renal Physiol. 2019 Jun 5. doi: 10.1152/ajprenal.00497.2018. [Epub ahead of print]

6.The role of inflammasomes in kidney disease.
Komada T, Muruve DA.
Nat Rev Nephrol. 2019 Jun 4. doi: 10.1038/s41581-019-0158-z. [Epub ahead of print] Review.

7.Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease.
Nagayama I, Masuda T, Nakagawa S, Murakami T, Ohara K, Matsuoka R, Kobayashi T, Maeshima A, Akimoto T, Saito O, Muto S, Nagata D.
Intern Med. 2019 Jun 1;58(11):1587-1591. doi: 10.2169/internalmedicine.2174-18. Epub 2019 Feb 1.

8.Inflammasome-Independent and Atypical Processing of IL-1β Contributes to Acid Aspiration-Induced Acute Lung Injury.
Mizushina Y, Karasawa T, Aizawa K, Kimura H, Watanabe S, Kamata R, Komada T, Mato N, Kasahara T, Koyama S, Bando M, Hagiwara K, Takahashi M.
J Immunol. 2019 May 20. pii: ji1900168. doi: 10.4049/jimmunol.1900168. [Epub ahead of print]

9.Knockout of Na-glucose-cotransporter SGLT1 mitigates diabetes-induced upregulation of nitric oxide synthase-1 in macula densa and glomerular hyperfiltration
Song P, Huang W, Onishi A, Patel R, Kim YC, van Ginkel C, Fu Y, Freeman B, Koepsell H, Thomson SC, Liu R, Vallon V.
Am J Physiol Renal Physiol. 2019 May 15. doi: 10.1152/ajprenal.00120.2019. [Epub ahead of print]

10.Peritoneal Dialysis and Malignancy: An Experience With a Patient Complicated by Gastric Carcinoma.
Akimoto T, Muto S, Kutsuwada T, Kutsuwada K, Nagata D.
Clin Med Insights Case Rep. 2019 Mar 12;12:1179547619835176. doi: 10.1177/1179547619835176. eCollection 2019.

11.SGLT2 inhibition and renal urate excretion: the role of luminal glucose, GLUT9 and URAT1.
Novikov A, Fu Y, Huang W, Freeman B, Patel R, van Ginkel C, Koepsell H, Busslinger M, Onishi A, Nespoux J, Vallon V.
Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F173-F185.

12.
Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018.
Okada H, Yasuda Y, Kashihara N, Asahi K, Ito T, Kaname S, Kanda E, Kanno Y, Shikata K, Shibagaki Y, Tsuchiya K, Tsuruya K, Nagata D, Narita I, Nangaku M, Hattori M, Hamano T, Fujimoto S, Moriyama T, Yamagata K, Yamamoto R, Wakasugi M, Ashida A, Usui J, Kawamura K, Kitamura K, Konta T, Suzuki Y, Tsuruoka S, Nishio S, Hamano T, Fujii N, Fujii H, Wada T, Yokoyama H, Aoki K, Akiyama D, Araki SI, Arima H, Ishikawa E, Ishikura K, Ishizuka K, Ishimoto T, Ishimoto Y, Iseki K, Itabashi M, Ichioka S, Ichikawa K, Ichikawa D, Inoue S, Imai T, Imamura H, Iwata Y, Iwazu Y, Usui T, Uchida K, Egawa M, Ohara S, Omori N, Okada R, Okuda Y, Ozeki T, Obata Y, Kai H, Kato N, Kanasaki K, Kaneko Y, Kabasawa H, Kawaguchi T, Kawasaki Y, Kawashima K, Kawano H, Kikuchi K, Kihara M, Kimura Y, Kurita N, Koike K, Koizumi M, Kojima C, Goto S, Konomoto T, Kohagura K, Komatsu H, Komaba H, Saito C, Sakai Y, Sakaguchi Y, Satonaka H, Jimi K, Shimizu A, Shimizu S, Shirai S, Shinzawa M, Sugiyama K, Suzuki T, Suzuki H,Suyama K, Segawa H, Takahashi K, Tanaka K, Tanaka T, Tsunoda R, Tsuruta Y, Nakakura H, Nagasawa Y, Nakanishi K, Nagahama M, Nakaya I, Nanami M, Niihata K, Nishi S, Nishiwaki H, Hasegawa S, Hasegawa M, Hanada K, Hayashi H, Harada R, Hishida M, Hirano D, Hirahashi J, Hirama A, Hirayama K, Fukagawa M, Fukuda A, Fujii Y, Fujisaki K, Furuya F, Hoshino J, Hosojima M, Honda K, Masuda T, Matsui K, Matsukuma Y, Matsumura H, Mii A, Miura K, Mitobe M, Miyasato Y, Miyamoto S, Miwa S, Yazawa M, Yata Y,Yamamoto Y, Watanabe K.
Clin Exp Nephrol. 2019 Jan;23(1):1-15.